
Hemant Mathai Mathew
Examiner (ID: 3637, Phone: (571)270-5604 , Office: P/3742 )
| Most Active Art Unit | 3742 |
| Art Unit(s) | 3742 |
| Total Applications | 359 |
| Issued Applications | 176 |
| Pending Applications | 2 |
| Abandoned Applications | 182 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17212968
[patent_doc_number] => 20210346304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => ENCAPSULATED CELLS PRODUCING CYTOCHROME P450 AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/123941
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17123941
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/123941 | ENCAPSULATED CELLS PRODUCING CYTOCHROME P450 AND METHODS OF USE THEREOF | Dec 15, 2020 | Abandoned |
Array
(
[id] => 18272442
[patent_doc_number] => 20230093684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/784139
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784139
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784139 | STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY | Dec 9, 2020 | Pending |
Array
(
[id] => 17198754
[patent_doc_number] => 20210338848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACROPHAGE-RELATED DISORDERS USING CARBOHYDRATE-BASED MACROMOLECULAR CARRIER
[patent_app_type] => utility
[patent_app_number] => 17/118224
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118224 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACROPHAGE-RELATED DISORDERS USING CARBOHYDRATE-BASED MACROMOLECULAR CARRIER | Dec 9, 2020 | Pending |
Array
(
[id] => 16976245
[patent_doc_number] => 20210220482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => MITOCHONDRIAL COPPER DEPLETION REPROGRAMS THE METABOLISM OF TRIPLE NEGATIVE BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/116357
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116357
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116357 | MITOCHONDRIAL COPPER DEPLETION REPROGRAMS THE METABOLISM OF TRIPLE NEGATIVE BREAST CANCER | Dec 8, 2020 | Abandoned |
Array
(
[id] => 18193428
[patent_doc_number] => 20230046947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => REACTIVE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/781687
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781687 | REACTIVE CONJUGATES | Dec 2, 2020 | Pending |
Array
(
[id] => 18483721
[patent_doc_number] => 20230211024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => METHODS OF IMAGING USING MULTIPLE IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/782132
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782132 | METHODS OF IMAGING USING MULTIPLE IMAGING AGENTS | Dec 2, 2020 | Pending |
Array
(
[id] => 16710518
[patent_doc_number] => 20210077665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => METHODS AND DEVICES FOR LYMPHATIC TARGETING
[patent_app_type] => utility
[patent_app_number] => 17/106141
[patent_app_country] => US
[patent_app_date] => 2020-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17106141
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/106141 | METHODS AND DEVICES FOR LYMPHATIC TARGETING | Nov 28, 2020 | Abandoned |
Array
(
[id] => 16686879
[patent_doc_number] => 20210069354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => METHOD OF TRANSPORTING AN AGENT ACROSS BLOOD-BRAIN, BLOOD-COCHLEAR OR BLOOD-CEREBROSPINAL FLUID BARRIER
[patent_app_type] => utility
[patent_app_number] => 16/951736
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16951736
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/951736 | METHOD OF TRANSPORTING AN AGENT ACROSS BLOOD-BRAIN, BLOOD-COCHLEAR OR BLOOD-CEREBROSPINAL FLUID BARRIER | Nov 17, 2020 | Abandoned |
Array
(
[id] => 18158688
[patent_doc_number] => 20230025280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PH RESPONSIVE COMPOSITIONS, FORMULATIONS, AND METHODS OF IMAGING A TUMOR
[patent_app_type] => utility
[patent_app_number] => 17/756190
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17756190
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/756190 | PH RESPONSIVE COMPOSITIONS, FORMULATIONS, AND METHODS OF IMAGING A TUMOR | Nov 16, 2020 | Pending |
Array
(
[id] => 16915805
[patent_doc_number] => 20210188897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => NEUROACTIVE STEROIDS AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/099568
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099568
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/099568 | NEUROACTIVE STEROIDS AND COMPOSITIONS AND METHODS THEREOF | Nov 15, 2020 | Abandoned |
Array
(
[id] => 16671179
[patent_doc_number] => 20210059942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => COMPOSITIONS AND METHODS OF TREATING THERAPY RESISTANT CANCER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/096268
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096268
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096268 | COMPOSITIONS AND METHODS OF TREATING THERAPY RESISTANT CANCER AND USES THEREOF | Nov 11, 2020 | Pending |
Array
(
[id] => 16822773
[patent_doc_number] => 20210138066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => REMOTE-CONTROLLED IMAGE-GUIDED DRUG DELIVERY VIA ULTRASOUND-MODULATED MOLECULAR DIFFUSION
[patent_app_type] => utility
[patent_app_number] => 17/092215
[patent_app_country] => US
[patent_app_date] => 2020-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092215 | REMOTE-CONTROLLED IMAGE-GUIDED DRUG DELIVERY VIA ULTRASOUND-MODULATED MOLECULAR DIFFUSION | Nov 6, 2020 | Pending |
Array
(
[id] => 18094653
[patent_doc_number] => 20220412994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => BIOMARKER OF DRUG-INDUCED CELLULAR TOXICITY AND DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/775217
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/775217 | BIOMARKER OF DRUG-INDUCED CELLULAR TOXICITY AND DEPRESSION | Nov 5, 2020 | Pending |
Array
(
[id] => 16686608
[patent_doc_number] => 20210069083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => METHOD FOR IMPROVING SKIN WHITENING POWER OF A SKIN WHITENING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/090347
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090347
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/090347 | METHOD FOR IMPROVING SKIN WHITENING POWER OF A SKIN WHITENING AGENT | Nov 4, 2020 | Abandoned |
Array
(
[id] => 18152045
[patent_doc_number] => 11564995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Peptide-nanoparticle conjugates
[patent_app_type] => utility
[patent_app_number] => 17/083601
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 37
[patent_no_of_words] => 10469
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083601 | Peptide-nanoparticle conjugates | Oct 28, 2020 | Issued |
Array
(
[id] => 16686615
[patent_doc_number] => 20210069090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => Epilatory Compositions
[patent_app_type] => utility
[patent_app_number] => 17/075758
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075758 | Epilatory compositions | Oct 20, 2020 | Issued |
Array
(
[id] => 16612005
[patent_doc_number] => 20210030658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => Epilatory Compositions
[patent_app_type] => utility
[patent_app_number] => 17/075882
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075882 | Epilatory compositions | Oct 20, 2020 | Issued |
Array
(
[id] => 16627363
[patent_doc_number] => 20210046016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => PRECISION CHEMICAL ABLATION AND TREATMENT OF TISSUES
[patent_app_type] => utility
[patent_app_number] => 17/076600
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076600
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/076600 | PRECISION CHEMICAL ABLATION AND TREATMENT OF TISSUES | Oct 20, 2020 | Pending |
Array
(
[id] => 16581317
[patent_doc_number] => 20210015719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => STABLE EMULSIFIED GEL COMPOSITION HAVING A HIGH CONCENTRATION OF ACTIVE COMPONENTS
[patent_app_type] => utility
[patent_app_number] => 17/064348
[patent_app_country] => US
[patent_app_date] => 2020-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4718
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064348
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/064348 | STABLE EMULSIFIED GEL COMPOSITION HAVING A HIGH CONCENTRATION OF ACTIVE COMPONENTS | Oct 5, 2020 | Abandoned |
Array
(
[id] => 16930861
[patent_doc_number] => 20210196750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => Liposomal-gold nanoparticles for drug delivery into the brain
[patent_app_type] => utility
[patent_app_number] => 17/063423
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063423 | Liposomal-gold nanoparticles for drug delivery into the brain | Oct 4, 2020 | Pending |